What Happened?
Cambridge, MA-based Cedilla Therapeutics Appointed Andrew Dawson as Chief Human Resources Officer
About the Company
We founded Cedilla at a time of fundamental and rapidly growing insight into the mechanisms underlying protein stability. Small molecules that degrade or stablize target proteins are precedented, but have been discovered serendipitously. Cedilla is taking an integrated approach to discover new drugs with this mode of action. Our present focus is to develop novel medicines in oncology, but this approach will also be applicable to other fields, including central nervous system disorders and genetic diseases. Cedilla launched with $56.2 million in Series A funding from Third Rock Ventures.
About the Person
Andrew Dawson is Chief Human Resources Officer at Cedilla Therapeutics. Previously, Andrew held various senior HR leadership roles in the industry.
Info Source
News
Short Profile